Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (5925)	1/21/1999 11:22:00 PM
From: FNS	Read Replies (1) of 6136

Henry, thanks for the clarification, but the group being down 1.09% means little when only 13 out of 49 biotech stocks were up (5 of which were up more than 5%)....and 36 out of 49 were down considerably!!! NERX and the other 5+% up stocks biased the group result. (Just like yesterday when the NAZ was up 7 but primarily due to MFST!!!) Overall, the bio's had a poor showing, and rightfully so in a big down market...which has been overbought!!! In regards to AGPH, sell stops triggered at 55 and the stock tumbled...now needs to consolidate and move on. The analysts can say whatever they want...hind sight always 20-20, but potential for earnings/drugs in the pipeline and business fundamentals will drive the market. It appears that AGPH is still longer term bullish. (IMHO!) I'm really not so concerned about the sector as I am about a select group of biotechs...and the competition. Sorry, I don't know if AGPH is run like a lean machine or how good their business management is...perhaps someone could comment, who has perviewed the 10Q or whatever. Thanks. FNS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next